Published on: December 29, 2017 at 10:00AM
Condition: Pancreatic Cancer
Interventions: Drug: Aldoxorubicin HCl; Biological: ALT-803; Biological: ETBX-011; Biological: GI-4000; Biological: haNK for infusion; Biological: avelumab; Biological: bevacizumab; Drug: Capecitabine; Drug: Cyclophosphamide; Drug: Fluorouracil; Drug: Leucovorin; Drug: nab-Paclitaxel; Drug: lovaza; Drug: Oxaliplatin; Procedure: SBRT
Sponsor: NantKwest, Inc.
Recruiting
http://ift.tt/2EftjId
No comments:
Post a Comment